Home › NDC Lookup › RxCUI directory › RxCUI 198153

Colchicine 0.5 MG / probenecid 500 MG Oral Tablet — RxCUI 198153

RxNorm drug concept · Semantic clinical drug
RxCUI 198153 Semantic clinical drug · SCD ● Current RxNorm concept 4 FDA products 4 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI198153
Official nameColchicine 0.5 MG / probenecid 500 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped4
Package NDCs mapped4
Reported Medicaid activity (SDUD)2,119 prescriptions · 20 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Probenecid: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Probenecid works differently from anti-inflammatory gout drugs like colchicine. Instead of just calming a flare, it actually helps your kidneys flush out more uric acid — the subst...
  • Why did my doctor prescribe probenecid for my gout? I thought gout was treated with other drugs.
  • Aspirin is one you really need to avoid with probenecid — even a small dose of aspirin blocks probenecid from doing its job of lowering uric acid. Ibuprofen and similar NSAIDs are...
  • Can I take aspirin or ibuprofen for pain while I'm on probenecid?
📖 Read our full Probenecid guide →

🕸️ Concept Web — How Colchicine 0.5 MG / probenecid 500 MG Oral Table... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Colchicine 0.5 MG / probenecid 500 MG Oral Tablet RxCUI 198153

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 3

    The active substance itself — no strength, form, or brand attached yet.

    • Colchicine 2683
    • Probenecid 8698
    • Colchicine / probenecid 214452
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Colchicine / probenecid Oral Tablet 239053
    • Colchicine / probenecid Oral Product 1155187
    • Colchicine / probenecid Pill 1155481
    • Oral Tablet 317541
    • Oral Product 1151131
    • Pill 1151133
  3. Clinical & branded drugs 2

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Colchicine 0.5 MG 315711
    • Probenecid 500 MG 316591

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Colchicine 0.5 MG SCDC · 315711
  • Probenecid 500 MG SCDC · 316591
  • Colchicine / probenecid Oral Tablet SCDF · 239053
  • Colchicine / probenecid Oral Product SCDG · 1155187
  • Colchicine / probenecid Pill SCDG · 1155481

📦 FDA Products & Package NDCs

4 products · 4 package NDCs
4 package NDCs map to RxCUI 198153 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00591-5325-01 100 TABLET in 1 BOTTLE, PLASTIC (0591-5325-01) Probenecid and Colchicine Actavis Pharma, Inc. 1982-10-01
16571-0832-01 100 TABLET in 1 CONTAINER (16571-832-01) Probenecid and Colchicine Rising Pharma Holdings, Inc. 2023-10-24
50742-0263-01 100 TABLET in 1 BOTTLE (50742-263-01) Probenecid and Colchicine Ingenus Pharmaceuticals, LLC 2019-05-16
70518-4644-00 50 POUCH in 1 BOX (70518-4644-0) / 1 TABLET in 1 POUCH (705... Probenecid and Colchicine REMEDYREPACK INC. 2026-04-28
Observed labelers: Actavis Pharma, Inc. (1) · Ingenus Pharmaceuticals, LLC (1) · REMEDYREPACK INC. (1) · Rising Pharma Holdings, Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ea · median
$0.7769
Range $0.7769–$0.7769 · middle 50% $0.7769–$0.7769 · 3 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.